1.
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study: Ceftolozane-Tazobatam for febrile neutropenia. Mediterr J Hematol Infect Dis [Internet]. 2020 Aug. 29 [cited 2026 Apr. 29];12(1):e2020065. Available from: https://www.mjhid.org/mjhid/article/view/2020.065